What is DoubleBridge Technologies?
Established in 1997, DoubleBridge Technologies serves as a critical infrastructure partner for life sciences organizations worldwide. The company specializes in high-stakes software development, application customization, and regulatory information management. By providing essential tools such as the ROSETTA eCTD Viewer and ROSETTA GnosisVault, the firm enables pharmaceutical and biotech entities to streamline their submission processes and ensure rigorous compliance. Their integration of artificial intelligence into regulatory workflows positions them as a leader in digital transformation for the healthcare industry, effectively bridging the gap between complex data processing requirements and actionable business intelligence.
How much funding has DoubleBridge Technologies raised?
DoubleBridge Technologies has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in DoubleBridge Technologies
PPP
Public-Private Partnership
What's next for DoubleBridge Technologies?
With this late-stage capital, DoubleBridge Technologies is well-positioned to accelerate its product roadmap and expand its global footprint. The strategic investment will likely be directed toward enhancing their AI-driven regulatory submission platforms and scaling their IT service offerings to meet the increasing demand for digitized compliance solutions. As the life sciences industry faces mounting pressure to reduce time-to-market for new therapies, DoubleBridge's focus on reliable, automated, and compliant software solutions provides a robust foundation for sustained growth and long-term value creation for its stakeholders.
See full DoubleBridge Technologies company page
